Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology
Disease Category: Lung Cancer
Trial Information
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer
The purpose of the study is to see if ipilimumab given with
paclitaxel/carboplatin will have clinical benefit when compared to
paclitaxel/carboplatin alone in previously untreated patients with
lung cancer.
Inclusion Criteria
- Men or Women 18 Years or Older
- Documented NSCLC or SCLC
- ECOG of 0 or 1
Exclusion Criteria
- Brain Metastases
- Autoimmune Disease
- Known HIV, Hep B or Hep C Infection
- Peripheral Neuropathy ³ Grade 2
Hopital Sainte Marguerite
Hopital Sainte Marguerite
270 Bd Sainte Marguerite
Marseille Cedex 9 13274
France
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
